What are the treatment options for gout?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Gout

The optimal management of gout involves a combination of pharmacological treatments for acute flares and long-term urate-lowering therapy, along with lifestyle modifications to prevent future attacks. 1

Acute Gout Flare Management

First-line Options:

  • NSAIDs: Naproxen 500mg twice daily for 5 days

    • Caution: Avoid in renal impairment, peptic ulcer disease, uncontrolled hypertension
    • Use with caution in diabetes or ongoing infection 1
  • Colchicine: Start within 36 hours of symptom onset

    • Low-dose regimen: 1.2 mg initially, followed by 0.6 mg one hour later
    • Important: Do not use the outdated high-dose regimen (continuing until GI side effects) 1, 2
    • Renal adjustment: For severe impairment, treatment course should not be repeated more than once every two weeks 2
    • For dialysis patients: Reduce to single 0.6 mg dose 2
  • Corticosteroids:

    • Oral: Prednisone 30-35 mg daily for 3-5 days
    • Intra-articular: For involvement of 1-2 joints
    • Intramuscular/IV: Methylprednisolone 0.5-2.0 mg/kg 1

For Severe or Refractory Cases:

  • Combination therapy: Consider for severe pain (≥7/10) or polyarticular involvement
    • Options: Colchicine + NSAIDs, oral corticosteroids + colchicine, or intra-articular steroids with any other modality 1
  • IL-1 inhibitors: Anakinra or canakinumab for refractory cases 1
  • ACTH: 25-40 IU subcutaneously as an alternative 1

Adjunctive Measures:

  • Topical ice application
  • Rest and elevation of affected joint 1

Long-term Management

Urate-Lowering Therapy (ULT)

  • Indications: Recurrent attacks (≥2 per year), tophaceous gout, chronic kidney disease 1

  • First-line: Allopurinol

    • Starting dose: 100 mg daily (lower in renal impairment)
    • Gradually titrate to target serum urate <6 mg/dL 1
  • Alternative options:

    • Febuxostat: When allopurinol is not tolerated (caution with cardiovascular risks)
    • Uricosuric agents (probenecid, sulphinpyrazone): Alternative to xanthine oxidase inhibitors
    • Pegloticase: Reserved for patients who failed other options 1
  • Important ULT principles:

    • Do not discontinue during acute attacks
    • Provide prophylaxis when initiating ULT (low-dose colchicine or NSAIDs)
    • Adequate dose titration to reach target serum urate 1

Lifestyle Modifications

  • Dietary restrictions:

    • Limit purine-rich foods (organ meats, shellfish)
    • Reduce alcohol intake, especially beer
    • Avoid high-fructose corn syrup-sweetened beverages 1, 3
  • Recommended intake:

    • Low-fat dairy products
    • Adequate hydration (at least 2 liters daily)
    • Regular, moderate physical activity 1
  • Weight management: Weight loss programs if overweight/obese 1

Special Considerations

Renal Impairment

  • Acute flares:

    • Mild-moderate impairment: Standard dosing with close monitoring
    • Severe impairment: Limit colchicine treatment course frequency
    • Dialysis: Reduced colchicine dose (0.6 mg single dose) 2
  • Prophylaxis:

    • Severe impairment: Start colchicine at 0.3 mg/day
    • Dialysis: 0.3 mg twice weekly 2

Hepatic Impairment

  • Acute flares:

    • Mild-moderate impairment: Standard dosing with monitoring
    • Severe impairment: Limit treatment frequency to once every two weeks 2
  • Prophylaxis:

    • Consider dose reduction in severe hepatic impairment 2

Common Pitfalls to Avoid

  • Discontinuing ULT during acute flares
  • Failing to provide prophylaxis when initiating ULT
  • Using high-dose colchicine regimens for acute flares
  • Stopping prophylaxis too early
  • Inadequate dose titration of allopurinol 1
  • Delaying treatment beyond 24 hours of symptom onset 1

References

Guideline

Gout Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis, treatment, and prevention of gout.

American family physician, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.